I gave Mr Roman Najdecki the CFO of IM Medical a call this arfternoon to discuss the Sigma deal.
He was saying that senior management are also "blown away" and "dumbfounded" by the markets reaction to such a significant announcement.
He said more details on the deal will be out shortly (in the IM Medical newsletter) Not sure if any of those details will make it to the market or not.
Once Sigma introduce the Intelliheart system into pharmacies nation wide, IMI will be looking at around 55,000 tests per annum (think it was per annum
) It then means that Sigma can sell a product to a customer if they need it under the Intelliheart name.
I guess perhaps thats where some might think that IMI miss out. But then again, they aren't in the bussiness of supplying drugs to people for their heart conditions.
Even Roman speculated that perhpas investors thought IMI might not have the capital to progress and were expecting some money in the last announcement in some way, shape or form.
Also the Intelliheart units going to the UAE will probably leave or be there by the first or second week of July and it only takes about 2 weeks of training.
All info is then sent back to Aus.
All in all it seemed like a very positve thing from IMI.
I wish i knew what the market whad been expecting